Catheter Precision (NYSEAMERICAN:VTAK) is a U.S.-based developer, manufacturer and marketer of over-the-wire and rapid exchange microcatheters, guide catheters and ancillary devices designed for diagnostic and interventional cardiology, peripheral vascular and neurovascular procedures. The company’s portfolio includes specialized, high–performance catheter products engineered to facilitate access to small or tortuous vessels, deliver therapeutic devices and contrast media, and enhance procedural efficiency and patient outcomes.
Since its founding in southern California in the early 1990s, Catheter Precision has invested in proprietary extrusion, braiding and molding technologies to produce catheters with consistent wall thickness, hydrophilic coatings and torque control. Over the years, the company has introduced incremental design innovations—such as atraumatic tapered tips and distal lumen markers—to meet evolving clinical requirements and to support a broad range of minimally invasive interventions.
Headquartered in San Clemente, California, Catheter Precision operates a U.S.-based manufacturing facility that adheres to rigorous quality and regulatory standards, including ISO 13485 certification and FDA registrations. The company’s products are distributed through a network of strategic partners and direct sales channels across North America, Europe, Asia Pacific and select emerging markets. Technical support teams work closely with physicians and catheterization laboratories to provide product training, case planning assistance and procedural troubleshooting.
Under the leadership of President and Chief Executive Officer Kevin Kremer, Catheter Precision continues to expand its product development pipeline and global footprint. The management team combines medical device experience with a focus on lean manufacturing, supply-chain resilience and ongoing collaboration with interventional specialists to address unmet clinical needs in cardiovascular and neurovascular care.
